Skip to main content

and
  1. Article

    Open Access

    "That is why I stopped the ART": Patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme

    As ART programmes in African settings expand beyond the pilot stages, adherence to treatment may become an increasing challenge. This qualitative study examines potential barriers to, and facilitators of, adhe...

    Mison Dahab, Salome Charalambous, Robin Hamilton, Katherine Fielding in BMC Public Health (2008)

  2. Article

    Open Access

    Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study

    Many national antiretroviral therapy (ART) programmes encourage providers to identify and address baseline factors associated with poor treatment outcomes, including modifiable adherence-related behaviours, be...

    Mison Dahab, Salome Charalambous, Alan S Karstaedt in BMC Public Health (2010)

  3. Article

    Open Access

    A study of patient attitudes towards decentralisation of HIV care in an urban clinic in South Africa

    In South Africa, limited human resources are a major constraint to achieving universal antiretroviral therapy (ART) coverage. Many of the public-sector HIV clinics operating within tertiary facilities, that we...

    Rachel Mukora, Salome Charalambous, Maysoon Dahab in BMC Health Services Research (2011)

  4. Article

    Open Access

    Valacyclovir in the treatment of acute retinal necrosis

    To report the outcome of oral valacyclovir as the sole antiviral therapy for patients with acute retinal necrosis (ARN).

    Simon RJ Taylor, Robin Hamilton, Claire Y Hooper, Lavnish Joshi in BMC Ophthalmology (2012)

  5. Article

    Open Access

    Missed Hospital Appointments of Patients Receiving Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

    The aim of this study was to investigate the frequency and duration of missed hospital appointments (MHAs) in a consecutive cohort of patients treated with ranibizumab for neovascular age-related macular degen...

    Michael Karampelas, Maria Pefkianaki, Angela Rees in Ophthalmology and Therapy (2015)

  6. Article

    Open Access

    Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial

    In the UK, macular laser is the treatment of choice for people with diabetic macular oedema with central retinal subfield thickness (CST) < 400 μm, as per National Institute for Health and Care Excellence guid...

    Noemi Lois, Evie Gardner, Norman Waugh, Augusto Azuara-Blanco, Hema Mistry in Trials (2019)

  7. Article

    Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

    The management of diabetic retinopathy (DR) has evolved considerably over the past decade, with the availability of new technologies (diagnostic and therapeutic). As such, the existing Royal College of Ophthal...

    Winfried M. Amoaku, Faruque Ghanchi, Clare Bailey, Sanjiv Banerjee, Somnath Banerjee in Eye (2020)

  8. Article

    The impact of COVID policies on acute ophthalmology services—experiences from Moorfields Eye Hospital NHS Foundation Trust

    Louisa Wickham, Gordon Hay, Robin Hamilton, Jack Wooding, Harry Tossounis in Eye (2020)

  9. Article

    Open Access

    Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre Trial

    To report the mean change in Early Treatment Diabetic Retinopathy Study (ETDRS) best-corrected visual acuity (BCVA) and reading performance (reading acuity and maximum reading speed (MRS) using the MNREAD test...

    Praveen J. Patel, Hari Jayaram, Maria Eleftheriadou in Ophthalmology and Therapy (2020)

  10. No Access

    Article

    Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration

    Single center, noninterventional cohort study to assess 10-year visual and anatomical outcomes following initiation of treatment with antivascular endothelial growth factor (anti-VEGF) agents in neovascular ag...

    Shruti Chandra, Cristina Arpa, Deepthy Menon, Hagar Khalid, Robin Hamilton in Eye (2020)

  11. Article

    Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

    .

    Winfried M. Amoaku, Faruque Ghanchi, Clare Bailey, Sanjiv Banerjee, Somnath Banerjee in Eye (2020)

  12. No Access

    Article

    An open-source data set of anti-VEGF therapy in diabetic macular oedema patients over 4 years and their visual acuity outcomes

    The objective of this paper is to evaluate visual acuity (VA) outcomes of intravitreal anti-vascular endothelial growth factor (VEGF) in diabetic macular oedema (DMO).

    Christoph Kern, Dun Jack Fu, Josef Huemer, Livia Faes, Siegfried K. Wagner in Eye (2021)

  13. No Access

    Article

    Prefilled Eylea Syringe: our recent experience

    Eleni Karatsai, Shruti Chandra, Sandro Fasolo, Sobha Sivaprasad, Robin Hamilton in Eye (2021)

  14. Article

    Open Access

    A virtual-clinic pathway for patients referred from a national diabetes eye screening programme reduces service demands whilst maintaining quality of care

    To evaluate the potential of an integrated virtual medical retina clinic in secondary care for diabetic patients screened and referred by the UK National Diabetic Eye Screening Program (DESP).

    Livia Faes, Dun Jack Fu, Josef Huemer, Christoph Kern, Siegfried K. Wagner in Eye (2021)

  15. Article

    Outcomes following implementation of a high-volume medical retina virtual clinic utilising a diagnostic hub during COVID-19

    To describe the clinical outcomes following implementation of a high-volume medical retina virtual clinic utilising a diagnostic hub.

    Daren Hanumunthadu, Khadra Adan, Kerry Tinkler, Konstantinos Balaskas in Eye (2022)

  16. Article

    Medical retina hotline: Service evaluation and assessment of efficacy of a novel system in a tertiary care hospital

    Aditi Ashok Kumar Agarwal, Ricardo Alberto Romero Fontenlos, Deepthy Menon in Eye (2022)

  17. Article

    Open Access

    The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice

    Untreated neovascular age-related macular degeneration (nAMD) can lead to severe and permanent visual impairment. The chronic nature of the disease can have a significant impact on patients’ quality of life an...

    Ian Pearce, Winfried Amoaku, Clare Bailey, Louise Downey, Richard Gale in Eye (2022)

  18. No Access

    Article

    Comparison of anatomical and functional outcomes of treating myopic choroidal neovascularization with bevacizumab or ranibizumab

    To compare results of treatment with bevacizumab and ranibizumab injections in myopic choroidal neovascularization (mCNV).

    Malgorzata Woronkowicz, Robin Hamilton, Sue Lightman in International Ophthalmology (2023)